Oncological outcomes from trimodality therapy receiving definitive doses of neoadjuvant chemoradiation (≥60 Gy) and factors influencing consideration for surgery in stage III non-small cell lung cancer
2017 ◽
Vol 2
(3)
◽
pp. 259-269
◽
Keyword(s):
2013 ◽
Vol 87
(2)
◽
pp. S203
Keyword(s):
2017 ◽
Vol 12
(11)
◽
pp. S1875
◽
Keyword(s):
2012 ◽
Vol 84
(3)
◽
pp. S580
1999 ◽
Vol 13
(2)
◽
pp. 424-429
◽
Keyword(s):
Keyword(s):
2013 ◽
Vol 87
(2)
◽
pp. S180
◽
Keyword(s):